Partial Ossicular Replacement Prosthesis Market Size, Share and Global Trend By Material (Titanium, Hydroxyapatite, Others), By Patient Type (Adult, Paediatric), By End User (Hospitals, ENT Clinics, Ambulatory Surgery Centers, Others), and Regional Forecast, 2024-2032
KEY MARKET INSIGHTS
Ossiculoplasty or Ossicular chain reconstruction is a surgical procedure performed to repair and reconstruct the natural motion and function of the ossicles or the small bones in the middle ear. Various conditions affect the movement and functionality of three tiny bones in the middle ear namely the malleus, the incus and the stapes bones, which if left untreated can lead to mild or severe hearing loss.
There are two major types of ossicular reconstruction procedures, a Total Ossicular Replacement Prosthesis (TORP), and a Partial Ossicular Replacement Prosthesis (PORP). Various conditions including chronic ear diseases, infection, or a trauma can lead to damage to the ossicles in the middle ear.
To gain extensive insights into the market, Request for Customization
Increasing prevalence of chronic ear diseases such as cholesteatoma, otitis media, and other conditions are leading towards an increasing number of people around the world suffering from mild to severe hearing loss. According to the World Health Organization (WHO) statistics, in 2012 an estimated 5.2% population in the world were suffering from hearing loss. This combined with higher efficiency of partial ossicular replacement prosthesis as compared to hearing aids in the treatment of hearing loss, and increasing preference by surgeons for the minimally invasive procedure, are some of the major factors which are expected to drive the global partial ossicular replacement prosthesis market during the forecast period.
However, lack of awareness among patient population towards the surgical procedures, and comparatively higher cost of the surgical procedure are some of the factors expected to restrain the growth of the global partial ossicular replacement prosthesis market by 2026.
Key Players Covered
Some of the major companies operating in the global partial ossicular replacement prosthesis market are Medtronic, Olympus Corporation, Heinz Kurz GmbH Medizintechnik, GRACE MEDICAL, and Spiggle & Theis.
SEGMENTATION
SEGMENTATION | DETAILS |
By Material | · Titanium · Hydroxyapatite · Others |
By Patient Type | · Adult · Paediatric |
By End-User | · Hospitals · ENT Clinics · Ambulatory Surgery Centres · Others |
By Geography | · North America (the USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) · Latin America (Brazil, Mexico and Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa) |
Among the segmentation, the titanium among material segment is projected to dominate the global market in 2018, owing to better biocompatibility, and reduced inference with MRI and CT diagnostic procedures.
Key Insights
- Prevalence of ear disease by key countries
- Key mergers and acquisitions
- Technological advancements in ossicular replacement prosthesis products
- Recent industry developments such as partnerships, mergers, and acquisitions
Regional Analysis
North America is projected to dominate the global partial ossicular replacement prosthesis market during the forecast period owing to increasing preference towards minimally invasive surgical procedures in the U.S. and Canada. Combined with adequate reimbursement policies in the region, is leading to the increasing number of patients undergoing partial ossicular replacement procedures. The market in Asia Pacific region is projected to register comparatively higher CAGR from 2019-2026, owing to a large patient pool in emerging countries such as China and India along with increasing awareness about surgical treatment of ear diseases.
Key Industry Developments
- In March 2019, a team of doctors in South Africa successfully implanted worlds’s first 3D printed ossicular implant. During this procedure, titanium was utilized as implant material due its higher biocompatible rate.
- In August 2018, Advanced Bionics AG announced the FDA approval of HiRes Ultra 3D cochlear implant. The newly developed device offers hassle free operations while conducting MRI examinations.
- Ongoing
- 2023
- 2019-2022
-
Get in Touch with Us
-
US +1 833 909 2966 ( Toll Free )
-
